The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Regulation of Estrogen Receptor Messenger Ribonucleic Acid and Protein Levels in Human Breast Cancer Cell Lines by Sex Steroid Hormones, Their Antagonists, and Growth Factors
Open accessAbstract
Since sex steroid hormones and growth factors are known to modulate the proliferation of breast tumors, we have studied the effects of estrogen and progestin, their antagonists, and growth factors on the regulation of estrogen receptor (ER) mRNA and protein levels in T47D breast cancer cells, which contain low levels of ER, and in two sublines of MCF-7 cells which contain high ER levels. The mRNA levels were measured by Northern blot analysis using λOR8, a cDNA probe for ER, and protein levels were measured by hormone binding or Western blot analysis. Treatment of T47D cells with estradiol (E2) caused a 2.5-fold incre ase in ER mRNA (6.6 kilobases) levels after 48 h. The progestin R5020 evoked a marked decrease in ER mRNA and protein levels to 20% of control values, while the antiprogestin RU38,486 caused no change in ER. In MCF-7 cells, the effect of E2 on ER levels was dependent on the prior growth history of the cells. In cells grown in low estrogen [5% charcoal-dextran-treated calf serum with phenol red for 8 yr (MCF-7-K2)], which are still E2 responsive, treatment with E2, the antiestrogen LY117018, or both produced little change in ER mRNA or protein; in contrast, ER mRNA and protein were reduced by E2 to 40% and 50% of control levels, respectively, in MCF-7 cells (denoted MCF-7-K1) which had been maintained routinely in medium containing 5% calf serum. This decrease in ER mRNA was dose dependent; 10−11 E2 reduced levels to 60%, and 10−10m E2 evoked the maximal drop to 40% of the control level in 2 days. LY117018 alone did not alter ER mRNA levels in these cells, but it completely prevented the down-regulation of ER by E2. Administration of progestin, but not antiprogestin, along with E2 partially prevented the decrease in ER evoked by E2. Addition of epidermal growth factor or insulin-like growth factor-I to MCF-7-K1 cells, which increased cell proliferation, had no detectable effect on ER levels. Treatment with transforming growth factor-β, which decreased cell proliferation, reduced ER by about 20%. Hence, 1) whether there is up-or down-regulation of ER by E2 depends upon the cell line (T47D vs. MCF-7) and prior growth conditions; 2) E2 and LY117018 have different effects on ER regulation; 3) R5020 and RU38,486 regulate ER differently; and 4) the growth factors epidermal growth factor, insulin-like growth factor I, and transforming growth factor-β have only modest effects on ER levels. These findings suggest that the dominant factors regulating ER levels in these cells are the steroid hormone ligands themselves.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Sequence and Expression of Human Estrogen Receptor Complementary DNA
Greene, G. L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., & Shine, J. (1986) · Science · doi:10.1126/science.3753802 · Cited by 1,311
Self-citationBerthois, Y., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2496 · Cited by 1,307 · cited 3×
“Thus, these cells, like the original MCF-7-K1 cell line, are exposed to estrogenic components in phenol red in the medium (23, 28), but the MCF-7-K2 cells have been exposed for many years to very low, if any, serum estrogens.”
BackgroundMethodSelf-citationKnabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R., & Dickson, R. B. (1987) · Cell · doi:10.1016/0092-8674(87)90193-0 · Cited by 975
Cloning of the human estrogen receptor cDNA.
Walter, P., Green, S., Greene, G., Krust, A., Bornert, J. M., Jeltsch, J. M., Staub, A., Jensen, E., Scrace, G., & Waterfield, M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.7889 · Cited by 730
Self-citationEstrogenic Regulation of Growth and Polypeptide Growth Factor Secretion in Human Breast Carcinoma
DICKSON, R. B., & LIPPMAN, M. E. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-29 · Cited by 568
Immunochemical studies of estrogen receptors
Greene, G. L., Sobel, N. B., King, W. J., & Jensen, E. V. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90188-2 · Cited by 434
Self-citationContrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis, M. M., Robinson, S. P., SATYASWAROOP, P. G., & Jordan, V. C. (1988) · PubMed · Cited by 422
Katzenellenbogen, B. S., Kendra, K. L., Norman, M. J., & Berthois, Y. (1987) · PubMed · Cited by 403
Self-citationCoezy, E. D., Borgna, J., & Rochefort, H. (1982) · PubMed · Cited by 394
Cited by
Simerly, R. B., Swanson, L. W., Chang, C., & Muramatsu, M. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902940107 · Cited by 2,118
Physiological Action of Progesterone in Target Tissues*
Graham, J. D., & Clarke, C. L. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.4.0308 · Cited by 1,008
Nagel, S. C., vom Saal, F. S., Thayer, K. A., Dhar, M. G., Boechler, M., & Welshons, W. V. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.9710570 · Cited by 793
Lonard, D. M., Nawaz, Z., Smith, C. L., & O'Malley, B. W. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80259-2 · Cited by 562
Molecular effects of genistein on estrogen receptor mediated pathways
Wang, T. T. Y., Sathyamoorthy, N., & Phang, J. M. (1996) · Carcinogenesis · doi:10.1093/carcin/17.2.271 · Cited by 489
Singh, M., Sétáló, G., Guan, X., Warren, M., & Toran-Allerand, C. D. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01179.1999 · Cited by 470
Novel Mechanisms of Estrogen Action in the Brain: New Players in an Old Story
Toran-Allerand, C. D., Singh, M., & Sétáló, G. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0177 · Cited by 427
Flouriot, G. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4688 · Cited by 425
The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response
Castellano, L., Giamas, G., Jacob, J., Coombes, R. C., Lucchesi, W., Thiruchelvam, P., Barton, G., Jiao, L. R., Wait, R., Waxman, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906947106 · Cited by 329
Estrogen Receptor-β mRNA Expression in Rat Ovary: Down-Regulation by Gonadotropins
Byers, M., Kuiper, G. G. J. M., Gustafsson, J.-A., & Park-Sarge, O.-K. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.2.9887 · Cited by 304
Alarid, E. T. (1999) · Molecular Endocrinology · doi:10.1210/me.13.9.1522 · Cited by 300
Davey, J. C., Bodwell, J. E., Gosse, J. A., & Hamilton, J. W. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm013 · Cited by 266
Cyr61 promotes breast tumorigenesis and cancer progression
Tsai, M.-S., Bogart, D. F., Castañeda, J. M., Li, P., & Lupu, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205682 · Cited by 189
Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line.
POULIN, R., SIMARD, J., LABRIE, C., PETITCLERC, L., DUMONT, M., LAGACÉ, L., & LABRIE, F. (1989) · Endocrinology · doi:10.1210/endo-125-1-392 · Cited by 115
SIMARD, J., DAUVOIS, S., HAAGENSEN, D. E., LÉVESQUE, C., MÉRAND, Y., & LABRIE, F. (1990) · Endocrinology · doi:10.1210/endo-126-6-3223 · Cited by 107
Oestrogen functions in skin and skin appendages
Thornton, M. J. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.617 · Cited by 82
“A number of studies have reported that the ratio of ERα to ERβ is altered in some pathologies including cancer [73-76].”
BackgroundAuto-regulation of the estrogen receptor promoter
Castles, C. G., Oesterreich, S., Hansen, R., & Fuqua, S. A. W. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00023-x · Cited by 80
“It is generally accepted that estrogen can down-regulate ER expression [13] in breast cancer cells, and others have shown that estrogen can also up-regulate ER expression in some cells [14], but little is known about the mechanism(s) involved in these events.”
Suzuki, S., & Handa, R. J. (2004) · Endocrinology · doi:10.1210/en.2003-1688 · Cited by 74
Forbes-Lorman, R., Auger, A. P., & Auger, C. J. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.012 · Cited by 12
Metadata
- Authors
- Read, L. D., Greene, G. L., & Katzenellenbogen, B. S.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1989-02
- Volume
- 3
- Issue
- 2
- Pages
- 295-304
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W1999186716
- Cited by
- 257
- References
- 35
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.